Stimulations of these anti-apoptotic molecules, which can enhance cancer cell proliferation and survival mechanisms, emphasize that the p53 reactivation under MCT-1 oncogenic stress fails to slow down the tumor development. This evidence concerns the gene TP53 and cancer.